Improving Lipid Optimization Quality and Treatment Options in ASCVD

Improving Lipid Optimization Quality and Treatment Options in ASCVD

The goal of this project is to study different approaches to improve the utilization of guideline directed medicines to lower cholesterol in patients with or at high risk of atherosclerosis (cholesterol buildup in the arteries).

This project will include approximately 300 patients who, based on current guidelines, would benefit from optimized lipid management. The project is testing the most effective methods to notify providers and patients and inform them that their patients may benefit from further lipid optimization. It will utilize systematic allocation at the provider level in which clinicians are assigned to either the direct Provider Notification Strategy or the Pharmacist-Driven Medication Management Strategy, ensuring that all patients continue to receive guideline-based care while eliminating the risk of treatment selection bias. Approximately 100 providers to ensure a sufficient number of patients are included.

Inclusion Criteria:

• >18 years old and <=95 years old
• Established Atherosclerotic Cardiovascular Disease
• Diabetes
• Possible Familial Hypercholesterolemia (FH)
• High-Risk Primary Prevention

Exclusion Criteria:

• No PCP, cardiologist, endocrinologist, or nephrologist at MGB
• ESRD on dialysis
• Enrolled in a hospice program
• Advanced dementia